LUng CAncer focuS - Long-term Monitoring of Bronchogenic Carcinoma Patients (LUCAS)
LUCAS
LUng CAncer focuS - Long Term Non-interventional Monitoring of Diagnostic and Treatment Patterns in Patients With Bronchogenic Carcinoma (LUCAS)
1 other identifier
observational
2,300
1 country
7
Brief Summary
Long-term non-interventional monitoring of diagnostics and treatment patterns in newly diagnosed patients in selected pneumology centers in Czech republic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2018
Longer than P75 for all trials
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2018
CompletedFirst Submitted
Initial submission to the registry
October 31, 2019
CompletedFirst Posted
Study publicly available on registry
January 14, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedMarch 9, 2022
March 1, 2022
7 years
October 31, 2019
March 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Overall survival (OS)
Time from randomization until death from any cause
60 months of follow-up
Progression-free survival (PFS)
Time from randomization until disease progression or death
any treatment during 60 months of follow-up
Time to treatment discontinuation (TTD)
time from starting a medication until treatment discontinuation or death
any treatment during 60 months of follow-up
Secondary Outcomes (1)
Time to next treatment (TTNT)
60 months of follow-up
Eligibility Criteria
all newly diagnosed patients in participating pulmonology centers
You may qualify if:
- \- clinical diagnosis of lung cancer (C34 in MKN classification)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
University hospital Brno
Brno, 62500, Czechia
University hospital Hradec Kralove
Hradec Králové, 50005, Czechia
University hospital Olomouc
Olomouc, 77900, Czechia
University hospital Plzen
Pilsen, 30599, Czechia
University Thomayer hospital
Prague, 140 59, Czechia
University hospital Motol
Prague, 15006, Czechia
University hospital Bulovka
Prague, Česká Republika, 18000, Czechia
Related Publications (1)
Venclicek O, Skrickova J, Brat K, Fischer O, Havel L, Hrnciarik M, Marel M, Opalka P, Krakorova G, Rozsivalova D, Kultan J, Mullerova A, Zarnayova L, Smickova P, Vasakova M, Gyorfy Z, Jirousek M, Krejci D, Krejci J, Zuna P, Svaton M, Hrda K, Duba J, Alahakoon J, Svoboda M, Silar J. Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry. Anticancer Res. 2021 Nov;41(11):5549-5556. doi: 10.21873/anticanres.15368.
PMID: 34732425DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martina Koziar Vasakova, Prof.
University Thomayer hospital Prague
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 31, 2019
First Posted
January 14, 2020
Study Start
June 1, 2018
Primary Completion
May 31, 2025
Study Completion
May 31, 2025
Last Updated
March 9, 2022
Record last verified: 2022-03